If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 7 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Mesothelioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Oncolytic Virotherapy Medicine & Life Sciences
Eukaryotic Initiation Factor-4F Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Eukaryotic Initiation Factor-4E Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2024

Research Output 2006 2019

A review of avelumab in locally advanced and metastatic bladder cancer

Rao, A. & Patel, M. R., Feb 8 2019, In : Therapeutic Advances in Urology. 11, p. 1756287218823485

Research output: Contribution to journalReview article

Urinary Bladder Neoplasms
United States Food and Drug Administration
Cell Death
Drug Approval
1 Citation (Scopus)

Immune Checkpoint Inhibitors in ROS1-Rearranged Non–Small Cell Lung Cancer: A Report of Two Cases

Jain, A., Fujioka, N. & Patel, M. R., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. e165-e167

Research output: Contribution to journalLetter

Non-Small Cell Lung Carcinoma

Impact of Immune Therapy in Elderly Patients with Non-Small Cell Lung Cancer (NSCLC): A Systematic Review

Kumar, M., Patel, M. R., Smith, A. & Bakker, C. J., Apr 2019.

Research output: Contribution to conferencePoster

Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer

De, A., Jacobson, B. A., Peterson, M. S., Stelzner, M. E., Jay-Dixon, J., Kratzke, M. G., Patel, M. R., Bitterman, P. B. & Kratzke, R. A., May 1 2019, In : Cancer gene therapy. 26, 5-6, p. 157-165 9 p.

Research output: Contribution to journalArticle

Eukaryotic Initiation Factor-4F
Non-Small Cell Lung Carcinoma
4 Citations (Scopus)

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Patel, M. R., Dash, A., Jacobson, B. A., Ji, Y., Baumann, D., Ismail, K. & Kratzke, R. A., Nov 1 2019, In : Cancer gene therapy. 26, 11-12, p. 411-418 8 p.

Research output: Contribution to journalArticle

Oncolytic Virotherapy
Vesicular Stomatitis
Non-Small Cell Lung Carcinoma